Showing results (151-160 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|April 20, 2018
Huntington's disease: novel therapeutic perspectives hanging in the balanceAna Saavedra, Gerardo García-Díaz Barriga, Esther Pérez-Navarro, et al.Expert Opinion on Therapeutic Targets|July 4, 2017
GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancerLuis Molina, Carlos D Figueroa, Kanti D Bhoola, et al.Expert Opinion on Therapeutic Targets|June 12, 2018
Progranulin as a therapeutic target for dementiaDaniela Galimberti, Chiara Fenoglio, Elio ScarpiniExpert Opinion on Therapeutic Targets|June 12, 2018
Mutant ATRX: uncovering a new therapeutic target for gliomaSantiago Haase, María Belén Garcia-Fabiani, Stephen Carney, et al.Expert Opinion on Therapeutic Targets|June 12, 2018
Two acute myeloid leukemia patient subsets are identified based on the constitutive PI3K-Akt-mTOR signaling of their leukemic cells; a functional, proteomic, and transcriptomic comparisonIna Nepstad, Kimberley J Hatfield, Elise Aasebø, et al.Expert Opinion on Therapeutic Targets|September 13, 2018
Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targetsYoshihiro Ito, Jonathan R Hart, Peter K VogtExpert Opinion on Therapeutic Targets|July 18, 2018
Potential neuroprotective role of astroglial exosomes against smoking-induced oxidative stress and HIV-1 replication in the central nervous systemSabina Ranjit, Benjamin J Patters, Kelli A Gerth, et al.Expert Opinion on Therapeutic Targets|June 1, 2019
A preclinical overview of emerging therapeutic targets for glomerular diseasesPaola Cassis, Carlamaria Zoja, Luca Perico, et al.Expert Opinion on Therapeutic Targets|May 11, 2019
Visfatin as a therapeutic target for rheumatoid arthritisEloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, et al.Expert Opinion on Therapeutic Targets|May 14, 2019
Genome-wide bioinformatics analysis of FMN, SAM-I, glmS, TPP, lysine, purine, cobalamin, and SAH riboswitches for their applications as allosteric antibacterial drug targets in human pathogenic bacteriaNikolet Pavlova, Robert PenchovskyPageof 232